However, MYCN knockdown did not downregulate MDM2 in two of three MYCN amplified neuroblastoma cell lines (16, 20) or in RB176 (17), a retinoblastoma line in which MDM2 promotes MYCN expression (Figure 1A). The gene discussed is MYCN; the disease is neuroblastoma.